COMBINATORIAL CHEMISTRY: CURRENT APPROACH

Similar documents
EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

Receptor Based Drug Design (1)

RECENT TRENDS IN PHARMACEUTICAL CHEMISTRY FOR DRUG DISCOVERY

Computational chemical biology to address non-traditional drug targets. John Karanicolas

AMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE

Combinatorial Heterogeneous Catalysis

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

Welcome to Week 5. Chapter 9 - Binding, Structure, and Diversity. 9.1 Intermolecular Forces. Starting week five video. Introduction to Chapter 9

An automated synthesis programme for drug discovery

CH MEDICINAL CHEMISTRY

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Early Stages of Drug Discovery in the Pharmaceutical Industry

Molecularly imprinted polymers

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL

BA, BSc, and MSc Degree Examinations

Biology Slide 1 of 34

pharmaceutical industry- drug discovery

COMBINATORIAL COMPOUND LIBRARIES FOR DRUG DISCOVERY: AN ONGOING CHALLENGE

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Study of Non-Covalent Complexes by ESI-MS. By Quinn Tays

In silico pharmacology for drug discovery

Pharmaceutical e-learning at the University of Innsbruck

LIFE-EDESIA project: overview and Actions B3, B5. Ferdinando Fiorino Francesco Frecentese

DivCalc: A Utility for Diversity Analysis and Compound Sampling

Fall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers)

Enamine Golden Fragment Library

Label-Free Sandwich Imaging Ellipsometry Immunosensor for. Serological Detection of Procalcitonin

10/18/2006. Biotage A Life Science Technology Company

Virtual affinity fingerprints in drug discovery: The Drug Profile Matching method

Chemists are from Mars, Biologists from Venus. Originally published 7th November 2006

Introduction to Chemoinformatics and Drug Discovery

Chemical Space. Space, Diversity, and Synthesis. Jeremy Henle, 4/23/2013

College of the Canyons Biotechnology Program

HPLC AND 13 C NMR FOR ANALYSIS OF TRANSAMIDATION IN A DYNAMIC COMBINATORIAL CHEMISTRY SYSTEM

Quantitative structure activity relationship and drug design: A Review

SIFT-MS SELECTED ION FLOW TUBE MASS SPECTROMETRY TECHNOLOGY OVERVIEW \ SYFT TECHNOLOGIES

Introduction. OntoChem

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery

Dynamic Combinatorial Chemistry in the identification of new host guest interactions: proof of principle

Keywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )

Ping-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.

MITOCW enzyme_kinetics

Principles of Drug Design

Reaxys Improved synthetic planning with Reaxys

Savannah State University New Programs and Curriculum Committee Summary Page Form I

SIFT-MS. technology overview

CHEMISTRY (CHE) CHE 104 General Descriptive Chemistry II 3

Biophysical Techniques in Drug Discovery

CONTINUOUS FLOW CHEMISTRY (PROCESSING) FOR INTERMEDIATES AND APIs

FORENSIC TOXICOLOGY SCREENING APPLICATION SOLUTION

CHEMISTRY (CHEM) CHEM 5800 Principles Of Materials Chemistry. Tutorial in selected topics in materials chemistry. S/U grading only.

Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Moscow Institute of Physics and Technology, Institutsky 9, Dolgoprudny , Russia 2

به نام خدا. New topics in. organic chemistry. Dr Morteza Mehrdad University of Guilan, Department of Chemistry, Rasht, Iran

Synthetic organic compounds

Medicinal Chemistry and Chemical Biology

CHEM 121: Chemical Biology

Structural Bioinformatics (C3210) Molecular Docking

Structural biology and drug design: An overview

Modelling of Possible Binding Modes of Caffeic Acid Derivatives to JAK3 Kinase

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

The Origin of Life on Earth

Proteomics. Areas of Interest

Pavel Kočovský Outline of Research

Everyday NMR. Innovation with Integrity. Why infer when you can be sure? NMR

DiscoveryGate. One place for the answers you need. Chulalongkorn University, Thailand

Analysis and screening of combinatorial libraries using mass spectrometry

Programme Specification MSc in Cancer Chemistry

Similarity methods for ligandbased virtual screening

Principles of Drug Design

Microreactors in Chemistry! Christina Moberg!

Stephen McDonald, Mark D. Wrona, Jeff Goshawk Waters Corporation, Milford, MA, USA INTRODUCTION

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015

CHEMISTRY (CHEM) CHEM 208. Introduction to Chemical Analysis II - SL

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

In-depth, 2 Credit Courses Descriptions

Small-Molecule Kinetics

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

CHEMISTRY (CHEM) Chemistry (CHEM) 1

Polymer-Supported Reagents as Versatile Tools in Combinatorial Chemistry and Total Synthesis

Introduction to FBDD Fragment screening methods and library design

In Silico Investigation of Off-Target Effects

Enzymes Part III: Enzyme kinetics. Dr. Mamoun Ahram Summer semester,

REQUIREMENTS FOR A MAJOR IN CHEMISTRY (B.A.): Eight lecture courses, the associated laboratory courses, and senior research (52 credits)

Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland

mrna proteins DNA predicts certain possible future health issues Limited info concerning evolving health; advanced measurement technologies

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction

Focus Series Peptide Synthesizers

Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability

Using AutoDock for Virtual Screening

New Synthetic Technologies in Medicinal Chemistry

TANDEM MASS SPECTROSCOPY

FACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques

Structure-Based Drug Discovery An Overview

Notes of Dr. Anil Mishra at 1

The Chemistry department approved by the American Chemical Society offers a Chemistry degree in the following concentrations:

Biochemistry: A Review and Introduction

Transcription:

COMBINATORIAL CHEMISTRY: CURRENT APPROACH Dwivedi A. 1, Sitoke A. 2, Joshi V. 3, Akhtar A.K. 4* and Chaturvedi M. 1, NRI Institute of Pharmaceutical Sciences, Bhopal, M.P.-India 2, SRM College of Pharmacy, Chennai, T.N.-India 3, Shi RNS College of Pharmacy, Gormi, Gwalior, M.P.-India 4, Faculty of Pharmacy, Integral University, Lucknow, U.P-India 5, GRY Institute of Pharmacy, Khargone, M.P.-India * Corresponding Author ABSTRACT Combinatorial chemistry is one of the important new methodologies developed by researchers in the pharmaceutical industry to reduce the time and costs associated with producing effective and competitive new drugs. Through the rapidly evolving technology of combi-chemistry, it is now possible to produce chemical libraries to screen for novel bioactivities. INTRODUCTION The main objective of combinatorial chemistry is synthesis of arrays of chemical or biological compounds called libraries.(1) These libraries are screened to identify useful components, such as drug candidates. Synthesis and screening are often treated as separate tasks because they require different conditions, instrumentation, and scientific expertise. Synthesis involves the development of new chemical reactions to produce the compounds, while screening aims to identify the biological effect of these compounds, such as strong binding to proteins and other biomolecular targets (2). With this technique, the migration times of the ligand-receptor pair are significantly longer than the unreactive ligands, and can be interrogated by electrospray mass spectrometry. The mass spectrometric method often provides a direct structural identification of the ligand, either by determination of its molecular weight or by collision-induced dissociation experiments. In the latter case, the molecular ion is selected by a primary mass spectrometer and is driven into a region of high-pressure inert gas for fragmentation. The fragment ions are then used to reconstruct the original molecular structure. This direct approach to screening and 5

assaying has the advantage that the screening is carried out in solution rather than on a solid support, and it avoids steric problems associated with resin-bound molecules. At present the approach seems limited to libraries of about 1000 compounds because of interference from unbound ligands, and limited by sensitivity issues. New strategies using mass spectrometry may eliminate this limit. (3)(4) PRINCIPLE The key of combinatorial chemistry is that a large range of analogues is synthesized using the same reaction conditions, the same reaction vessels. In this way, the chemist can synthesis many hundreds or thousands of compounds in one time instead of preparing only a few by simple methodology. In contrast to this approach, combinatorial chemistry offers the potential to make every combination of compound A1 to An with compound B1 to Bn. The range of combinatorial techniques is highly diverse, and these products could be made individually in a parallel or in mixtures, using either solution or solid phase techniques. Whatever the technique used the common denominator is that productivity has been amplified beyond the levels that have been routine for the last hundred years.( 5) METHOD OF SYNTHESIS

I. COMBINATORIAL SYNTHESIS ON SOLID-PHASE The use of solid support for organic synthesis relies on three interconnected requirements: (6)(7). II.COMBINATORIAL SYNTHESIS IN SOLUTION The benefit of preparing libraries on resin beads has been explained as offering advantages in handling, especially where a need to separate excess reagents from the reaction products is attached to the resin. In most of case a simple filtration effects a rapid purification and the product are ready to further synthetic transformation. But it should be remember that using solid phase chemistry brings several disadvantages as well. Clearly the range of chemistry available on solid phase is limited and it is difficult to monitor the progress of reaction when the substrate and product are attached to the solid phase. (8) III. PARALLEL SOLUTION PHASE SYNTHESIS (9)

APPLICATION Combinatorial chemistry is one of the important new methodologies developed by academics and researchers in the pharmaceutical, agrochemical, and biotechnology industries to reduce the time and costs associated with producing effective, marketable, and competitive new drugs. Simply put, scientists use combinatorial chemistry to create large populations of molecules, or libraries that can be screened efficiently en masse. By producing larger, more diverse compound libraries, companies increase the probability that they will find novel compounds of significant therapeutic and commercial value. The field represents a convergence of chemistry and biology, made possible by fundamental advances in miniaturization, robotics, and receptor development. And not surprisingly, it has also captured the attention of every major player in the pharmaceutical, biotechnology, and agrochemical arena. While combinatorial chemistry can be explained simply, its application can take a variety of forms, each requiring a complex interplay of classical organic synthesis techniques, rational drug design strategies, robotics, and scientific information management. This article will provide a basic overview of existing approaches to combinatorial chemistry, and will outline some of the unique information management problems that it generates. Combinatorial chemistry is a promising new field that stands to revolutionize the chemical industry, and

demands completely new scientific information management solutions. Combinatorial chemists will be able to meet their goals if they can find ways to plan libraries quickly, produce libraries that better interrogate biological assays, and learn from past screening results. Using software that can orchestrate the planning, building, screening, and interpretation of synthesized libraries, combinatorial chemistry programs will begin to realize their promise of minimizing the time and cost associated with bringing new molecular entities to market. (10) CONCLUSION Combinatorial chemistry is a technology for creating molecules en masse and testing them rapidly for desirable properties-continues to branch out rapidly. One-molecule-at-a-time discovery strategies, many researchers see combinatorial chemistry as a better way to discover new drugs, catalysts, and materials. Compared with conventional one-molecule-at-a-time discovery strategies, many researchers see combinatorial chemistry as a better way to discover new drugs, catalysts, and materials. It is a method for reacting a small number of chemicals to produce simultaneously a very large number of compounds, called libraries, which are screened to identify useful products such as drug candidates and a method in which very large numbers of chemical entities are synthesized by condensing a small number of reagents together in all combinations defined by a small set of reactions. REFERENCES 1. Gallop et al., J. Med. Chem., 1994, 37, 1233-51 2. To identify nucleic acid aptamers: Latham et al., Nucl. Acids. Res., 1994, 22, 2817-2822 3. To identify RNA ligands to reverse transcriptase: Chen and Gold, Biochemistry, 1994, 33, 8746-56 4. To identify catalytic antibody specific to a particular transition state: Posner, Trends. Biochem. Sci., 1994, 19, 145-150

5. To identify inhibitors of carbonic anhydrase enzyme: Baldwin, J. J., Burbaum, J. J., Henderson, I., Ohlmeyer, M. H. J., J. Am. Chem. Soc., 1995, 117, 5588-5589. 6. Geysen, H. M., Meleon, R. H., Barteling, S. J., Proc. Nat. Acad. Sci. USA, 1984, 81, 3998-4002. 7. Armstrong R., PCT 95/02566 Hunter, T., Curr. Cell Biol., 1989, 1, 1168. 8..Bradford, D., Flint, A., Tonks, N. K., Science, 1994, 263, 1397.Gordon et al., J. Med. Chem., 1994, 37, 1385-401 9. Gallop et al., J. Med. Chem., 1994, 37, 1233-51 10. To identify RNA ligands to reverse transcriptase: Chen and Gold, Biochemistry, 1994, 33, 8746-56